Latest Articles

Publication Date
Epigenetic biomarkers of progestin-resistance in endometriosis.

Published: March 18, 2026, midnight
Repeatedly occurring retrograde menstruation intensifies central sensitization driven by neuroinflammation in endometriosis models.

This study investigated how chronic pelvic pain (CPP) develops using rhesus macaques with naturally occurring endometriosis and a multiple-lesion induction mouse model (MIM), as repeated retrograde menstruation is considered an …

Published: March 17, 2026, midnight
Impact of combined oral contraceptives and progestin-only pills on psychological and sexual well-being of women with endometriosis: A systematic review.

Women with endometriosis frequently experience psychological and sexual concerns. Combined oral contraceptives (COCs) and progestin-only pills (POPs) represent first-line treatments for the disease, yet their potential negative impact on mood …

Published: March 12, 2026, midnight
GLP-1–Progestin and Endometrial Cancer Risk - Conexiant

GLP-1–Progestin and Endometrial Cancer Risk Conexiant

Published: March 2, 2026, 5:01 p.m.
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... - Medical Dialogues

Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... Medical Dialogues

Published: Feb. 17, 2026, 3:15 p.m.
Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk - geneonline.com

Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk geneonline.com

Published: Feb. 16, 2026, 6:10 a.m.
Study Finds GLP-1 Agonists Combined with Progestin Reduce Endometrial Cancer Risk by 66% - geneonline.com

Study Finds GLP-1 Agonists Combined with Progestin Reduce Endometrial Cancer Risk by 66% geneonline.com

Published: Feb. 16, 2026, 5:37 a.m.
Dydrogesterone and Letrozole Combination for the Treatment of Endometriosis: A Mechanism-Based Therapeutic Approach.

Endometriosis is a complex, estrogen-dependent disease with limited effective treatments that often focus on symptom management rather than addressing the underlying pathology. Current therapies, such as progestins and GnRH agonists, …

Published: Feb. 13, 2026, midnight
Impact of hormonal treatments for endometriosis on the reproductive microbiome: a systematic review.

The reproductive microbiome plays a key role in disease progression and fertility in women with endometriosis. Vaginal and endometrial dysbiosis has been increasingly linked to inflammation, impaired reproductive outcomes, and …

Published: Feb. 12, 2026, midnight
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk - Medscape

GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk Medscape

Published: Feb. 11, 2026, 8:49 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!